Hematopoietic Stem Cell Transplantation for Severe Thalassemia Patients from Haploidentical Donors Using a Novel Conditioning Regimen-Reference-Cited by-同舟云学术

Hematopoietic Stem Cell Transplantation for Severe Thalassemia Patients from Haploidentical Donors Using a Novel Conditioning Regimen

Published:2020-06 Issue:6 Volume:26 Page:1106-1112
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Anurathapan Usanarat,Hongeng Suradej,Pakakasama Samart,Songdej Duantida,Sirachainan Nongnuch,Pongphitcha Pongpak,Chuansumrit Ampaiwan,Charoenkwan Pimlak,Jetsrisuparb Arunee,Sanpakit Kleebsabai,Rujkijyanont Piya,Meekaewkunchorn Arunotai,Lektrakul Yujinda,Iamsirirak Pornchanok,Surapolchai Pacharapan,Sirireung Somtawin,Sruamsiri Rosarin,Wahidiyat Pustika Amalia,Andersson Borje S.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Survival and complications in thalassemia;Borgna-Pignatti;Ann N Y Acad Sci,2005

2. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel;Angelucci;Haematologica,2014

3. Marrow transplantation for patients with thalassemia: results in class 3 patients;Lucarelli;Blood,1996

4. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years;Sodani;Blood,2004

5. Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamics profile with therapeutic drug monitoring;Gaziev;Blood,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation;Pediatric Blood & Cancer;2024-09-03

2. An evaluation of exagamglogene autotemcel for the treatment of sickle cell disease and transfusion-dependent beta-thalassaemia;Expert Opinion on Biological Therapy;2024-09-02

3. Uniform graft-versus-host disease prophylaxis using post-transplantation cyclophosphamide, methotrexate, and cyclosporine following peripheral blood hematopoietic stem cell transplantation from matched and haploidentical donors for transfusion-dependent thalassemia: a retrospective report from the BMF-WG of Hunan province, China;Transplantation and Cellular Therapy;2024-09

4. Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know;Oncology and Therapy;2024-06-15

5. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease;Bone Marrow Transplantation;2024-03-14